Recent Developments in the CNS Drug Market:Industry Analysis Report @ http://www.researchmoz.us/recent-developments-in-the-cns-drug-market-report.html

1. Recent Developments in the CNS Drug Market
This report reviews the global market for CNS prescription drugs and recent developments within the
marketplace, including collaborative agreements, recent clinical trial results and new product approvals across
8 key therapy areas.
Despite recent technological advances, relatively few novel treatments have been launched within the CNS
market over the last decade. Many of the current market leaders are beginning to face generic competition or
will do within the next five years.
However, the overall neuroscience market is worth approximately US$145.3 billion, and with the CNS
market forming a large part of that, there is room for investment to be made. Significant unmet need remains
for a number of CNS conditions and the pipeline of drug development remains strong.
This new report from Espicom reviews the recent developments in drug therapy for a number of CNS
disorders, providing five-year sales for the current market leaders and forecasts for these and potential
therapies to 2020, where available.
Key market questions answered by the report:
Who are the current leading players in the CNS drugs market? What are the current treatment options for
schizophrenia and bipolar disorder? What are the recent FDA approvals for depression drugs? Which new
therapies will increase the value of the multiple sclerosis market?
The Recent Developments in the CNS Drugs Market report is the foolproof business resource for any industry
executive that needs to fully understand the current and forecasted CNS market. The need for hard facts and
statistics to back up everyday business decisions is essential and it is this report that can provide you with the
answers.
table Of Contents
foreword 1
executive Summary 3
the Cns Drugs Market 4
market Overview 4
the Leading Players 6
astrazeneca 8
biogen Idec 8
eli Lilly 8
Recent Developments in the CNS Drug Market

2. endo Pharmaceuticals 8
forest Laboratories 9
glaxosmithkline 9
johnson & Johnson 9
lundbeck 10
otsuka 10
pfizer 10
purdue Pharma/mundipharma/napp Pharmaceuticals 11
shire 11
teva 11
cns Market Sectors 12
pain 12
types Of Pain 12
nociceptive Pain 12
neuropathic Pain 12
psychogenic Pain 13
current Treatment Options For Pain 13
pain Drug Sales And Forecasts 15
neuropathic Pain Management 17
the World Health Organization’s Pain Ladder 18
the Pain Pipeline 18
pipeline Highlights And Recent Developments 21
levadex (dihydroergotamine) 21
moxduo Ir (morphine+oxycodone; Q8003) 22
mnk-795 (oxycodone+acetaminophen) 22
posidur (saber-bupivacaine) 23
remoxy (oxycodone) 23
zohydro Er (hydrocodone Bitartrate) 24
schizophrenia And Bipolar Disorder 25
current Treatment Options For Schizophrenia And Bipolar Disorder 25
schizophrenia Drug Sales And Forecasts 26
the Schizophrenia And Bipolar Disorder Pipeline 28
pipeline Highlights And Recent Developments 29
aripiprazole 29
cariprazine 29
fanapt/fanaptum (iloperidone) 30
depression 31
current Treatment Options For Depression 31
depression Drug Sales And Forecasts 32
Recent Developments in the CNS Drug Market

3. recent Fda Approvals For Depression 34
fetzima (levominacipram) 34
brintellix (vortioxentine) 35
the Depression Pipeline 37
pipeline Highlights And Recent Developments 38
teva Scraps Nuvigil Development For Depression 38
bms Terminates Development Of Bms-820836 For Treatment-resistant Depression 38
attention Deficit Hyperactivity Disorder (adhd) 39
current Treatment Options For Adhd 39
adhd Drug Sales And Forecasts 40
the Adhd Pipeline 43
pipeline Highlights And Recent Developments 43
edivoxetine (ly2216684) 43
metadoxine Er (mg01ci) 44
eb-1020 Sr Phase Iia Pilot Study Initiated 44
highland Raises Funds To Conduct Studies With Lead Compounds 45
durect And Orient Select Lead Formulation For Oradur-adhd Programme 45
epilepsy 47
current Treatments For Epilepsy 48
epilepsy Drug Sales And Forecasts 49
the Epilepsy Pipeline 50
pipeline Highlights And Recent Developments 51
zebinix (eslicarbazepine) 51
banzel/inovelon (rufinamide) 52
brivaracetam 52
multiple Sclerosis 54
relapsing Forms Of Multiple Sclerosis 54
primary And Secondary Progressive Multiple Sclerosis 54
current Treatments For Ms 55
drug Sales And Forecasts 55
the Ms Pipeline 59
pipeline Highlights And Recent Developments 60
plegridy (peginterferon Beta-1a) 60
relonsiv (interferon Beta-1b) 60
s1p Receptor Agonists 61
arbaclofen 61
sativex For Ms Spasticity 62
neu2 Project In Support Of Diagnostic For Ms 62
alzheimer’s Disease 63
current Treatments For Ad 63
alzheimer’s Disease Drug Sales And Forecasts 63
the Ad Pipeline 65
pipeline Highlights And Recent Developments 68
Recent Developments in the CNS Drug Market

4. diagnosing Ad With Pet Imaging 68
lundbeck And Otsuka Development Agreement For Lu Ae58054 68
fixed-dose Combination Of Memantine Er And Donepezil (mdx-8704/ads-8704) 69
solanezumab 70
gammagard (immunoglobulin) 70
masitinib 71
bace Inhibitors 72
nnr Modulators 73
parkinson’s Disease 74
current Treatments For Pd 74
parkinson’s Disease Drug Sales And Forecasts 75
the Pd Pipeline 76
pipeline Highlights And Recent Developments 77
dopamine Precursor + Dopa Decarboxylase Inhibitor Combinations 77
adenosine 2a Receptor Inhibition 77
safinamide 78
sources 80
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Recent Developments in the CNS Drug Market